Jing Ma

Title: Innovations of Jing Ma in Cancer Treatment

Introduction

Jing Ma is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative research and inventions. His work focuses on the development of novel therapeutic methods that utilize advanced materials for effective drug delivery.

Latest Patents

Jing Ma holds a patent for "Amphiphilic dendrimers complexed with siRNA for treatment of cancer." This invention pertains to amphiphilic dendrimers complexed with Bcl3 siRNA. The amphiphilic dendriplexes described in the patent are biodegradable and exhibit enhanced siRNA delivery. These dendriplexes containing Bcl3 siRNA have been shown to inhibit cancer cell and tumor growth in vitro and in vivo without causing toxicity. The invention provides a method for treating cancer, particularly nasopharyngeal carcinoma, by administering a therapeutic amount of amphiphilic dendrimers complexed with Bcl3 siRNA. Additionally, pharmaceutical compositions containing these dendrimers are also included in the patent.

Career Highlights

Throughout his career, Jing Ma has worked with prestigious institutions, including the Université d'Aix-Marseille and The Chinese University of Hong Kong. His research has focused on innovative approaches to cancer therapy, showcasing his commitment to advancing medical science.

Collaborations

Jing Ma has collaborated with notable colleagues, including Ling Peng and K W Lo. These partnerships have contributed to the development of his groundbreaking inventions and have enhanced the impact of his research in the scientific community.

Conclusion

Jing Ma's innovative work in the field of cancer treatment exemplifies the potential of advanced materials in medicine. His patent on amphiphilic dendrimers complexed with siRNA represents a significant step forward in therapeutic strategies for cancer.